Protection of Healthcare Workers Against Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Reinfection.
作者信息
Dimeglio Chloé, Herin Fabrice, Miedougé Marcel, Martin-Blondel Guillaume, Soulat Jean-Marc, Izopet Jacques
机构信息
CHU Toulouse, Hôpital Purpan, Virology Laboratory, Toulouse, France.
INSERM UMR1291-CNRS UMR5051, Toulouse Institute for Infectious and Inflammatory Diseases (INFINITy), Toulouse, France.
出版信息
Clin Infect Dis. 2021 Oct 5;73(7):1323-1324. doi: 10.1093/cid/ciab069.
Abstract
摘要
相似文献
1
Protection of Healthcare Workers Against Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Reinfection.医护人员预防严重急性呼吸综合征冠状病毒2（SARS-CoV-2）再次感染
Clin Infect Dis. 2021 Oct 5;73(7):1323-1324. doi: 10.1093/cid/ciab069.
2
Symptomatic SARS-COV-2 reinfection: healthcare workers and immunosuppressed individuals at high risk.有症状的 SARS-CoV-2 再感染：医护人员和免疫抑制个体为高危人群。
BMC Infect Dis. 2021 Sep 6;21(1):923. doi: 10.1186/s12879-021-06643-1.
3
Asymptomatic Reinfection in 2 Healthcare Workers From India With Genetically Distinct Severe Acute Respiratory Syndrome Coronavirus 2.两名来自印度的医护人员无症状再次感染基因不同的严重急性呼吸综合征冠状病毒2。
Clin Infect Dis. 2021 Nov 2;73(9):e2823-e2825. doi: 10.1093/cid/ciaa1451.
4
Respiratory Viral Shedding in Healthcare Workers Reinfected with SARS-CoV-2, Brazil, 2020.巴西 2020 年医护人员再感染 SARS-CoV-2 的呼吸道病毒脱落情况。
Emerg Infect Dis. 2021;27(6):1737-1740. doi: 10.3201/eid2706.210558. Epub 2021 Apr 19.
5
Coronavirus Occurrence in the Household Influenza Vaccine Evaluation (HIVE) Cohort of Michigan Households: Reinfection Frequency and Serologic Responses to Seasonal and Severe Acute Respiratory Syndrome Coronaviruses.密歇根家庭流感疫苗评估（HIVE）队列中冠状病毒的发生：再感染频率和对季节性和严重急性呼吸综合征冠状病毒的血清学反应。
J Infect Dis. 2021 Jul 2;224(1):49-59. doi: 10.1093/infdis/jiab161.
6
Genomic Evidence of SARS-CoV-2 Reinfection Involving E484K Spike Mutation, Brazil.基因组证据表明巴西出现涉及 Spike 蛋白 E484K 突变的 SARS-CoV-2 再感染。
Emerg Infect Dis. 2021 May;27(5):1522-1524. doi: 10.3201/eid2705.210191. Epub 2021 Feb 19.
7
Genetic Evidence and Host Immune Response in Persons Reinfected with SARS-CoV-2, Brazil.巴西再次感染 SARS-CoV-2 患者的遗传证据和宿主免疫反应
Emerg Infect Dis. 2021 May;27(5):1446-1453. doi: 10.3201/eid2705.204912. Epub 2021 Apr 12.
8
Severe acute respiratory syndrome coronavirus 2 reinfection in a coronavirus disease 2019 recovered young adult: a case report.严重急性呼吸综合征冠状病毒 2 型在 2019 冠状病毒病康复的年轻成年人中的再感染：一例报告。
J Med Case Rep. 2021 Jul 16;15(1):382. doi: 10.1186/s13256-021-02965-5.
9
Duration of Viral Nucleic Acid Shedding and Early Reinfection With Severe Respiratory Syndrome Coronavirus 2 in Healthcare Workers and First Responders.医护人员和急救人员中严重呼吸综合征冠状病毒 2 的病毒核酸脱落持续时间和早期再感染。
J Infect Dis. 2021 Dec 1;224(11):1873-1877. doi: 10.1093/infdis/jiab504.
10
Reinfection or Reactivation of Severe Acute Respiratory Syndrome Coronavirus 2: A Systematic Review.再次感染或严重急性呼吸综合征冠状病毒 2 型的激活：系统评价。
Front Public Health. 2021 Jun 11;9:663045. doi: 10.3389/fpubh.2021.663045. eCollection 2021.
引用本文的文献
1
Protective effectiveness of previous infection against subsequent SARS-Cov-2 infection: systematic review and meta-analysis.既往感染对后续 SARS-CoV-2 感染的保护效力：系统评价和荟萃分析。
Front Public Health. 2024 Jun 20;12:1353415. doi: 10.3389/fpubh.2024.1353415. eCollection 2024.
2
Can the COVID-19 Pandemic Improve the Management of Solid Organ Transplant Recipients?新冠疫情能否改善实体器官移植受者的管理？
Viruses. 2022 Aug 24;14(9):1860. doi: 10.3390/v14091860.
3
SARS-CoV-2 reinfections during the first three major COVID-19 waves in Bulgaria.SARS-CoV-2 再感染在保加利亚前三次 COVID-19 大流行期间。
PLoS One. 2022 Sep 9;17(9):e0274509. doi: 10.1371/journal.pone.0274509. eCollection 2022.
4
Prediction of Vaccine Response and Development of a Personalized Anti-SARS-CoV-2 Vaccination Strategy in Kidney Transplant Recipients: Results from a Large Single-Center Study.肾移植受者中疫苗反应的预测及个性化抗SARS-CoV-2疫苗接种策略的制定：一项大型单中心研究的结果
J Pers Med. 2022 Jul 5;12(7):1107. doi: 10.3390/jpm12071107.
5
Decreased Efficiency of Neutralizing Antibodies from Previously Infected or Vaccinated Individuals against the B.1.617.2 (Delta) SARS-CoV-2 Variant.针对 B.1.617.2（德尔塔）SARS-CoV-2 变异株，先前感染或接种过疫苗的个体体内中和抗体的效率降低。
Microbiol Spectr. 2022 Aug 31;10(4):e0270621. doi: 10.1128/spectrum.02706-21. Epub 2022 Jul 5.
6
The REinfection in COVID-19 Estimation of Risk (RECOVER) study: Reinfection and serology dynamics in a cohort of Canadian healthcare workers.COVID-19 再感染风险评估（RECOVER）研究：加拿大医护人员队列中的再感染和血清学动态。
Influenza Other Respir Viruses. 2022 Sep;16(5):916-925. doi: 10.1111/irv.12997. Epub 2022 May 5.
7
Does a humoral correlate of protection exist for SARS-CoV-2? A systematic review.新型冠状病毒是否存在保护性体液相关因素？一项系统评价。
PLoS One. 2022 Apr 8;17(4):e0266852. doi: 10.1371/journal.pone.0266852. eCollection 2022.
8
Designing an optimal sequence of non-pharmaceutical interventions for controlling COVID-19.设计用于控制新冠病毒的非药物干预措施的最佳序列。
Eur J Oper Res. 2022 Dec 16;303(3):1372-1391. doi: 10.1016/j.ejor.2022.03.052. Epub 2022 Apr 1.
9
SARS-CoV-2 Reinfection Is a New Challenge for the Effectiveness of Global Vaccination Campaign: A Systematic Review of Cases Reported in Literature.SARS-CoV-2 再次感染对全球疫苗接种运动的效果构成新挑战：对文献报告病例的系统评价。
Int J Environ Res Public Health. 2021 Oct 19;18(20):11001. doi: 10.3390/ijerph182011001.
10
Serum nitrite and nitrate: A potential biomarker for post-covid-19 complications?血清亚硝酸盐和硝酸盐：新冠病毒感染后并发症的潜在生物标志物？
Free Radic Biol Med. 2021 Nov 1;175:216-225. doi: 10.1016/j.freeradbiomed.2021.08.237. Epub 2021 Aug 30.
Zotero 插件